New Pharmacy Transparency Requirements Reach Plan Sponsors Too

Federal reforms are putting plan sponsors’ oversight duties in sharper focus. The 2026 Consolidated Appropriations Act (signed February 3) adds PBM reporting rules that cover drug spending, pass-through rebates, and vendor compensation. Major provisions will generally...

Regulatory Takeaways from the 2026 SPBA Spring Conference

On March 30–31, MedBen President, COO & CPO Caroline Fraker attended the annual Society of Professional Benefits Administrators (SPBA) Spring Conference in Washington, D.C. Traditionally, this gathering of third-party administrator professionals focuses on...

Supreme Court Overturns the Chevron Deference Doctrine (and Why You Should Care)

Last month, in a 6 to 3 decision, the U.S. Supreme Court overturned the “Chevron Deference” doctrine. The Chevron Deference is a principle of administrative law that has required courts to defer to how regulatory agencies interpret federal statutes (legislation...